NEPH - Nephros, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
2.0200
+0.4200 (+26.25%)
At close: 04:00PM EDT
2.0000 -0.02 (-0.99%)
After hours: 07:58PM EDT
Stock chart is not supported by your current browser
Previous close1.6000
Open1.5400
Bid0.0000 x 2200
Ask0.0000 x 3100
Day's range1.4180 - 2.5000
52-week range0.9100 - 2.5000
Volume799,967
Avg. volume79,384
Market cap21.179M
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)-0.3800
Earnings date08 Aug 2023 - 14 Aug 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.00
  • GlobeNewswire

    Nephros Announces Results for Quarter Ended March 31, 2023

    First-Quarter Net Revenue of $3.7 Million;Achieves Positive Cash Flow Months Earlier than Forecast SOUTH ORANGE, NJ, May 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2023. Financial Highlights* Net revenue from continuing operations of $3.7 million, an increase of 71%Net loss from continui

  • GlobeNewswire

    Nephros Announces CEO Retirement and Succession Plan

    Robert Banks to Be Named President and Chief Executive Officer;Andy Astor to Remain as Advisor and Interim Chief Financial Officer SOUTH ORANGE, NJ, May 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that Andy Astor, President and Chief Executive Officer, will retire in the coming months, and that Robert Banks will be named President and Chief E

  • GlobeNewswire

    Nephros Schedules First Quarter 2023 Financial Results Conference Call

    SOUTH ORANGE, NJ , April 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 10, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 317-

  • GlobeNewswire

    Nephros Announces Preliminary Results for First Quarter 2023

    SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the quarter ended March 31, 2023. Nephros expects net revenue for the quarter ended March 31, 2023 to be approximately $3.7 million, a 69% increase from the quarter ended March 31, 2022. “We are very pleased with first-quarter revenue, which we

  • GlobeNewswire

    Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

    Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million SOUTH ORANGE, NJ, March 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Financial Highlights Fourth Quarter Ended December 31, 2022 – Consolidated Net revenue from continuing operatio

  • GlobeNewswire

    Nephros and Donastar Announce Strategic Partnership

    Donastar Becomes Exclusive Master Distributor of Nephros Commercial Water Filters for Food & Beverage and Hospitality Markets SOUTH ORANGE, NJ, March 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced a new partnership engaging Donastar Enterprises LLC as the exclusive master distributor for Nephros commercial filters in the food & beverage and hosp

  • GlobeNewswire

    Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call

    SOUTH ORANGE, NJ, Feb. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced it will file its fourth quarter and fiscal 2022 results on Wednesday, March 8, 2023 after market close and will host a conference call that same day at 4:30pm ET. Participants may dial into the call as follows: Domestic access: 1 (844) 808-7106 International access: 1 (412) 31

  • GlobeNewswire

    Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

    Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million;Active Customer Sites Continue to Climb SOUTH ORANGE, NJ, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced preliminary revenue results for the fourth quarter and fiscal year ended December 31, 2022. Net revenue for the quarter ended December 31, 2022, is expecte

  • GlobeNewswire

    Nephros Announces Results for Quarter Ended September 30, 2022

    Third-Quarter Net Revenue of $2.4 Million; Active Customer Sites Increase 18% YoY to a New Record Level SOUTH ORANGE, NJ, Nov. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2022. Financial HighlightsWater Filtration Business Segment Highlights* Net revenue from continuing operations of

  • GlobeNewswire

    Nephros Third Quarter 2022 Financial Results Conference Call

    SOUTH ORANGE, NJ, Oct. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its third-quarter financial results on Wednesday, November 2, 2022 after market close and will host a conference call that same day at 4:30 pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317

  • GlobeNewswire

    Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

    Sale Reduces Cash Burn, Includes Seven-Year Earn-Out Provision;Third Quarter Revenue Expected to be Approximately $2.5 Million; Active Customer Sites Increase 18% YoY SOUTH ORANGE, NJ, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has entered into a definitive agreement to sell its Pathogen Detection Systems (

  • GlobeNewswire

    Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

    SOUTH ORANGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced it has shipped 3,000 commercial water filters as part of its ongoing annual contract with Donastar Enterprises LLC and Tractor Beverage Co. in service of a national chain of fast-casual restaurants. “Earlier this year we established ourselves as an appr

  • GlobeNewswire

    Nephros Appoints Joe Harris to Its Board of Directors

    SOUTH ORANGE, NJ, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced the appointment of Joe Harris to its Board of Directors. “We are excited that Joe is joining our board,” said Andy Astor, President and Chief Executive Officer of Nephros. “He brings years of financial, sales, and marketing acumen to the board, with expe

  • Simply Wall St.

    Nephros, Inc. (NASDAQ:NEPH) Just Reported Earnings, And Analysts Cut Their Target Price

    Last week, you might have seen that Nephros, Inc. ( NASDAQ:NEPH ) released its second-quarter result to the market. The...

  • GlobeNewswire

    Nephros Announces Results for Quarter Ended June 30, 2022

    Second Quarter Net Revenue of $2.9 Million, a 27% Year-Over-Year Increase;Active Customer Sites Climb 21% to New Record SOUTH ORANGE, NJ, Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2022. Financial HighlightsWater Filtration Business Segment Highlights* Net rev

  • GlobeNewswire

    Nephros Second Quarter 2022 Financial Results Conference Call

    SOUTH ORANGE, NJ, July 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 10, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106Internatio

  • GlobeNewswire

    Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

    Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%;Number of Active Customer Sites Climbs 21% Year-Over-Year SOUTH ORANGE, NJ, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced preliminary revenue results for the second quarter ended June 30, 2022. Net revenue for the quarter ended June 30, 2022 is exp